Kristina Lachance
0000-0002-2697-268X
Publication & Citation Trends
Publications
0 total
CLINICAL BENEFIT OF ADDING RADIATION FOR IMMUNE CHECKPOINT INHIBITOR-REFRACTORY MERKEL CELL CARCINOMA: A 27-PATIENT ANALYSIS.
Cited by 0
Semantic Scholar
Immunotherapy response in immunosuppressed patients with Merkel cell carcinoma: analysis of 183 patients
Cited by 2
Semantic Scholar
Risk of disease progression after discontinuing immunotherapy in 105 patients with Merkel cell carcinoma who responded to PD-1 pathway blockade
Cited by 2
Semantic Scholar
LB1080 Pathologic margin negativity is not a guarantee: The risk of merkel cell carcinoma recurrence can be reduced with a single dose of radiation
Cited by 0
Semantic Scholar
Real-world outcomes of patients receiving salvage therapies for immune checkpoint inhibitor-resistant Merkel cell carcinoma: a rationale for future clinical trials
Cited by 3
Semantic Scholar
LB914 A single postoperative dose of radiotherapy (8 Gy) has comparable efficacy to a standard 5-week course for localized Merkel cell carcinoma (MCC)
Cited by 1
Semantic Scholar
113 Outcomes among 31 Merkel cell carcinoma patients with positive circulating tumor DNA but no clinically evident disease
Cited by 0
Semantic Scholar
783 Clinical benefit of adding radiation in immunotherapy-refractory Merkel cell carcinoma among 41 patients OA
Cited by 0
Semantic Scholar
Genetic Risk Factors for Early-Onset Merkel Cell Carcinoma.
Cited by 10
Semantic Scholar
Research Topics
Polyomavirus and related diseases
(61)
Full-Duplex Wireless Communications
(29)
Antenna Design and Analysis
(28)
Plant Virus Research Studies
(27)
Bacteriophages and microbial interactions
(19)
Affiliations
Virginia Commonwealth University
University of Washington
University Health System
University of Washington Medical Center
Active Medicine (United Kingdom)